Non-Billable / Non-Specific Code
ICD-10-CM D19 is the diagnosis code for Benign neoplasm of mesothelial tissue. This code falls under the section "Benign neoplasms, except benign neuroendocrine tumors" within Chapter 2 — Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where D19 sits in the ICD-10-CM classification helps ensure proper coding:
No, D19 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
D19 is the ICD-10-CM diagnosis code for "Benign neoplasm of mesothelial tissue". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
D19 is located in Section D10-D36 — "Benign neoplasms, except benign neuroendocrine tumors" within Chapter 2 of the ICD-10-CM Tabular List.
D19 has 4 sub-code(s) that provide more specific detail: D19.0, D19.1, D19.7, D19.9.
Use D19 when the patients documented diagnosis matches "Benign neoplasm of mesothelial tissue" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Benign neoplasm of mesothelial tissue is D19.
No, D19 is non-billable. Use a more specific sub-code for primary diagnosis billing.
D19 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, D19 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.